. 2024 Oct 3;5:xtae031. doi: 10.1093/femsmc/xtae031

Table 1.

Strains used in this study.

	Strain name	Relevant characteristics^b	References
Enterococcus faecalis laboratory strain	OG1RF (WT)	Oral isolate, Rif^R, Fus^R	Lab stock
Enterococcus faecalis clinical strains	TX0104 (Cat no. HM 201)	Blood isolate; Van^R	^a
	TX1322 (Cat no. HM 202)	Fecal isolate; Kan^R	^a
	MMH594 (Cat no. NR 31975)	Blood isolate; Erm^R, Gen^R	^a
	V587 (also termed EnGen0242) (Cat no. NR 31979)	Urine isolate; Van^R	^a
Enterococcus faecium clinical strains	503 (also termed 1 137 055) (Cat no. HM 952)	Unknown	^a
	EnGen0314 (Cat no. NR 31903)	Fecal isolate	^a
	EnGen0316 (Cat no. NR 31909)	Fecal isolate	^a
	EnGen0312 (Cat no. NR 31912)	Fecal isolate; Van^R	^a
	TX0082 (Cat no. HM 460)	Blood isolate; Amp^R, Erm^R, Kan^R, Van^R	^a
	ERV99 (Cat no. HM 975)	Peritoneal fluid isolate; Amp^R, Van^R, Gen^R, Strep^R	^a

The following strains were obtained through BEI Resources, NIAID, NIH as part of the Human Microbiome Project.

Resistant to kanamycin (Kan^R), vancomycin (Van^R), erythromycin (Erm^R), gentamycin (Gen^R), ampicillin (Amp^R), streptomycin (Strep^R), rifampcin (Rif^R), fusidic acid (Fus^R).